Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1987-1-30
pubmed:abstractText
Submucosal injections of teflon paste (suspension of teflon in glycerin) are used for therapy of ENT diseases. Little is known about the fate of the injected teflon particles. Is teflon phagocytosed and removed? Teflon paste was injected into the peritoneum of mice. After 48 days, we have found many teflon particles in peritoneal macrophages, in microphages and macrophages of regional lymph nodes and the spleen, and in Kupffer cells of the liver. We assume that phagocytosis and removal of the injected teflon particles occur in the patient, too. The particles are indigestible and, therefore, may block the phagocytic system. Phagocytes containing teflon induce local inflammation and fibrosis. Conclusive information about late effects is not available.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0340-1588
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
570-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
[Phagocytosis and transport of injected teflon paste. An animal experiment study].
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't